Details for 2019758683
Up to date per 03.04.2026
Actions
Details for 2019758683
Granted/Registered
European Patent
30.06.2021 A
20.03.2024 B1
22.08.2018
US
201862721113 P
C07F 5/02 20060101AFI20220812BHEP
Owner
Astrazeneca AB 151 85 SödertäljeSE
Representative
No representatives present
Inventor
WU, DedongAstraZeneca R&D Boston 35 Gatehouse Drive Waltham, MA 02451US
Information about Fees